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deletion of MMP-9 gene affects cartilage degradation at 8 weeks
post-injury.
Methods: Twenty eight MMP-9 knockout (FVB.Cg-MMP9) and
matching wildtype (FVB/NJ) mice (7 male and 7 female in each
group) were obtained from Jackson Laboratories (Bar harbor,
Maine), maintained in the animal facility at HSS with protocols
approved by IACUC. All the mice were 8-week-old (muscu-
loskeletal mature) at the time of surgery. The right knee of each
animal was exposed using medial parapatellar arthrotomy and in-
jured by a custom-made indenter (0.5 mm x 2mm) at the femoral
trochlear region (6 MPa, 5 minutes ∼20-40% cell death, based
on our previous in vitro study). The patella was then realigned
and the wound was closed in layers. The contralateral left knee
received the same surgical procedure without load-injury as a
sham control. Animal were sacriﬁced at 8 weeks after operation.
Collagen cleavage and proteoglycan loss was determined us-
ing immunoﬂuorescence (C12C mab) and Safranin-O/fast green
while collagen-network integrity (birefringence) was determined
by polar-light microscope. Joint inﬂammation was determined
by the thickening of synovial membrane (H&E), recruitment of
macrophages (F4/80 mab), and upregulation of TNF-α.
Results: All the animals were able to move freely one day af-
ter surgery and gained full locomotion (climbing cage and other
activities) about 3-6 day post operation. No signiﬁcance dif-
ference in animal behavior was noted between wildtype and
MMP-9 knockout mice. All the joints appeared normal (no
swelling/inﬂamed) at the time of sacriﬁce. Hematoxylin & eosin
staining showed a loss of cells in the injured region, which was
consistent with the loss of proteoglycan in the injured region
as determine by Safranin-O/fast green staining. Along with the
increase of PG loss/degradation was the signiﬁcant thickening of
synovial membrane as compared to sham-operated joint in the
wildtype mice. Further thickening of synovial membrane was also
found in the MMP-9 KO mice as compared to that of wildtype. An
increased MMP-9 staining was found in the injured wildtype joint
as compared to its contralateral knee. An increase of PG loss
and collagen cleavage along with a loss of collagen integrity was
found in the injured joint. Some RA-like inﬂammation (overgrown
synovial coverage and synovium invasion into cartilage) was
found in load-injured joint of MMP-9 knockout mouse. This ﬁnd-
ing is correlated with recruitment of macrophages and increased
accumlation of TNF-alpha in the MMP-9 KO mice.
Conclusions: Our ﬁnding supports our hypothesis that cartilage
damage induced chronical joint inﬂammation 8 weeks after injury
and the deletion of MMP-9 gene affects joint inﬂammation and
cartilage degradation/remodeling by recuiting pro-inﬂammatory
cells and modulating pro-inﬂammatory cytokines after overload
injury.
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ESTROGEN DEFICIENCY LEADS TO INCREASED PAIN
PERCEPTION IN A MODEL OF OSTEOARTHRITIS KNEE
PAIN
M.G. Chambers, J.L. Oskins, C. Lin, P.G. Mitchell
Musculoskeletal Drug Hunting Team Eli Lilly, Indianapolis, IN
Purpose: Osteoarthritis (OA) is a chronic debilitating joint dis-
ease with resulting pain in the affected joint. OA is most common
in post menopausal women and studies have shown that pain
perception increases post menopause suggesting a link to estro-
gen deﬁciency. In this study we investigated the rat monoiodoac-
etate (MIA) model, which develops pathology resembling some
aspects of human OA, to assess if ovariectomy (OVX) causes
an increase in knee pain compared to sham operated animals.
Methods: Female Sprague Dawley rats of 7-8 weeks of age
were randomized into 2 groups of 12 with one group being
ovariectomized and the other group sham ovariectomized. One
week post surgery the right knees of each rat were injected
with 0.3mg MIA in 50ul of saline and the left knees with 50ul of
saline. At 24 hours and 11 days post MIA injection incapacitance
testing was used to measure pain via differences in hind paw
weight bearing between the MIA and saline injected knees. Each
measurement was the average of 3 separate measurements
each measured over 1 second.
Results: At 24 hours after MIA injection the OVX animals ex-
hibited signiﬁcantly more pain than the sham OVX animal, as
measured by the difference in hind paw weight bearing (p<0.05;
see Table 1). By 11 days post MIA injection the pain in the sham
animals was the same as at 24 hours but the pain in the OVX
animals had signiﬁcantly increased (p<0.05; see Table 1).
Table 1. MIA Pain Measurements (Saline-MIA; Mean ± SEM) (g)
Treatment 24 hours 11 days
Sham OVX 21.7±0.87 22.6±0.67
OVX 31.9±0.42 45±3.41
Conclusions: These studies demonstrate the use of incapac-
itance testing in measuring joint pain in an animal model of
OA like pathology. Pain was signiﬁcantly greater in ovariec-
tomized animals verses intact animals suggesting that estrogen
deﬁciency exacerbates pain perception. These preclinical data
correlate well with epidemiological data which demonstrates that
post-menopausal women suffer from higher incidence and sever-
ity of joint-related pain than men or premenopausal women. The
mechanisms through which estrogen acts to affect pain are not
clear. There are however, preclinical data demonstrating that
estrogen effects a number of pain pathways including those
involved in serotonin uptake and signaling through glutamate
receptors.
In conclusion, these studies show that modulation of estrogen
receptors may be a potential therapeutic approach for treating
OA pain.
83
AN ACUTE IL-1 MEDIATED MODEL OF JOINT
DESTRUCTION
I. Scott, U. Rashid, S. Ball, A. Walding, P. Kerry, A. Midha,
S. Cruwys, S.J. Delaney
AstraZeneca, Loughborough, United Kingdom
Purpose: IL-1 is one of the key cytokines mediating cartilage
matrix degradation during osteoarthritis progression and recent
studies have shown that intra-articular anikinra can result in
a decrease in pain and improved joint function. To evaluate
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potential IL-1 antagonists we have developed and characterised
an acute model for IL-1 mediated joint destruction.
Methods: Rats were injected with 10 or 100 ng of IL-1β into
the left ankle and saline vehicle control in the right ankle and
analysed over a 2-24 h time course. Mechanical hyperalgesia,
swelling and histopathological changes of the ankle joints were
measured. The concentration of interleukin-6 (IL-6), nitric oxide,
prostaglandin E2 and glycosaminoglycan (GAG) was determined
in synovial lavage ﬂuid samples. RNA puriﬁed from whole ankle
joints was used to quantitatively measure expression of 48 genes
encoding inﬂammatory, degradative and cartilage extracellular
matrix (ECM) genes.
Results: Histological analysis demonstrated that IL-1β induced
a time-dependent increase in synovitis, synovial hypertrophy and
cellular debris in the intra-articular space compared to saline
injected ankles. IL-6 protein levels peaked 4 h after intra-articular
IL-1β injection, which is consistent with IL-6 gene expression
levels and increased ankle diameter after 4h. GAG concen-
trations in lavage ﬂuid samples were increased 4 and 24 h
after intra-articular IL-1β injection. However, there were no obvi-
ous histological changes in the articular cartilage noted over this
time course. RNA measurements indicated pro-inﬂammatory and
degradative genes such as COX-2, IL-1β, iNOS and ADAMTS5
were up-regulated by IL-1β.
Conclusions: IL-1β induced pain and inﬂammation of the joint
including synovitis and a corresponding increase in IL-6 protein
and gene expression levels. GAG release was detected in joint
lavage ﬂuid despite histological analysis showing no evidence
of cartilage damage. This therefore represents a useful acute
model with which to evaluate the efﬁcacy of IL-1 antagonists.
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HOW DOES VITAMIN D AFFECT BONE AND CARTILAGE
IN THE SPONTANEOUS GUINEA PIG MODEL OF
OSTEOARTHRITIS?
T.A. Hunt, R. Kandel, R. Renlund, R. Vieth, M. Grynpas
Samuel Lunenfeld Research Institute, Mount Sinai Hospital,
Toronto, ON, Canada
Purpose: Osteoarthritis (OA) is a progressive disorder character-
ized by degeneration of articular cartilage and bone remodeling.
Vitamin D is known to play a role in bone health; changes in
vitamin D levels may contribute to the development of OA. The
Framingham study showed that low serum levels of vitamin D
are associated with an increased risk for OA progression in the
knee. The aim is to examine the effect of either low or high
levels of vitamin D supplementation on the articular cartilage and
subchondral bone in the spontaneous guinea pig model of OA.
Methods: Male Dunkin-Hartley guinea pigs spontaneously de-
velop OA. 24 male guinea pigs were divided into 3 groups
(n=8) and received either a vitamin D-free (D-, 0 IU/day), con-
trol (153 IU/day) or high vitamin D (D+, 513 IU/day) diet. All
other nutritional contents were kept constant. The guinea pigs
were received at 2 months of age and vitamin D modulation
began upon arrival. The animals were harvested at 4, 6, and
9 months of age. Serum biochemistry was ﬁrst evaluated to
determine the response to the vitamin D dosing. To deﬁne the
cartilage response, a modiﬁed Mankin grading was used. Bone
mineral density (BMD) was evaluated using DXA, and bone histo-
morphometric parameters were evaluated using Bioquant Bone
Morphometry software. Subchondral bone quality was evaluated
using backscattered electron images to quantify the trabecu-
lae connectivity and mineralization. Kidney tissue was evaluated
histologically for the presence of calciﬁcation.
Results: There was a signiﬁcant (p<0.05) increase in blood
serum vitamin D levels as the dose increased. Calcium home-
ostasis was maintained, although a decrease (p<0.05) in phos-
phate was seen in the D- group at each time-point. An increase
(p<0.05) in the serum alkaline phosphatase was seen in the D-
compared to the D+ groups. Over time there was evidence of
OA seen by increasing Mankin scores. No signiﬁcant differences
were seen in the degree of OA changes between the treatment
groups. The BMD for both the control and D+ groups increased
(p<0.05) with age, while the BMD for the D- group plateaued
after 6 months and was signiﬁcantly lower (p<0.05) compared
to control and D+ groups by 9 months of age. An increase
(p<0.05) in bone volume was seen for all treatment groups from
4 to 6 months, explained by increasing trabecular thickness and
decreasing trabecular separation. The bone volume for the D-
group decreased from 6 to 9 months and was signiﬁcantly lower
compared to the control group. The osteoid volume decreased
(p<0.05) with time for the control and D+ groups, but the osteoid
volume for the D- group showed an increase with time and by 9
months was signiﬁcantly higher compared to the other treatment
groups. Although peak connectivity was seen for the D+ group
at 6 months, no differences were seen between the treatment
groups at 9 months for the femur. The mineralization proﬁle of
the subchondral trabecular bone shows that the D+ group main-
tained mineralization with age, while the control and D- groups
become hypomineralized. There were no detectable effects of
treatment on renal calciﬁcation.
Conclusions: Although increases were seen in the serum vita-
min D levels, the calcium homeostasis was maintained. Calcium
is tightly regulated in the body. The drop in phosphate is likely
due to an increase in parathyroid hormone and loss of phosphate
into the urine. The increase alkaline phosphatase indicated im-
paired mineralization for the D- group, which is supported by the
drop in BMD and hypomineralized bone for the D- group. Ulti-
mately, the D- group showed impaired bone quality (decreased
quantity, hardness, mineralization). The mineralization in the D+
group showed no changes with time, even though the Mankin
score indicated severe OA.
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SUBCHONDRAL BONE CHANGES IN A MURINE MODEL
FOR POSTMENOPAUSAL OSTEOARTHRITIS
Y.H. Sniekers, S.M. Botter, G.J. van Osch, J.P. van Leeuwen,
H. Weinans
Erasmus Medical Center, Rotterdam, The Netherlands
Purpose: In osteoarthritis (OA) the cartilage of joints is dam-
aged, but also bone changes take place. Since the prevalence
of OA increases strongly in women after the age of 50, and car-
tilage damage is increased after ovariectomy in several animal
models, it is suggested that hormone depletion plays a role in
the onset or progression of OA.
We hypothesize that hormone depletion may weaken the joint
tissues and make them more susceptible to OA. This means that
hormone depletion in combination with an additional trigger will
lead to (more) joint degeneration.
Our aim was to study both subchondral bone and cartilage
changes in a murine model for postmenopausal OA.
Methods: Female C3H/HeJ mice, aged 12 weeks, were used.
To induce mild OA, 0.5% iodoacetate (IA) was injected intra-
articularly into the right knee joints, whereas the left knee
joints were injected with saline. The mice were then divided
into two groups. One group (n=8) underwent an ovariectomy-
procedure (OVX), while another group (n=8) was sham-operated.
Thus, each knee joint belonged to one of the following groups:
Sham+Saline, Sham+IA, OVX+Saline, or OVX+IA. Using in-vivo
micro-CT (Skyscan 1076, Skyscan, Belgium), the mice were
scanned under anesthesia every 3 weeks for a period of 12
weeks to visualize subchondral bone changes in the knee joints.
After reconstruction and segmentation of the scans, tibial sub-
